Background: Vitamin D deficiency has been associated with adverse health outcomes. We examined genetic and environmental determinants of serum 25(OH)D 3 and 1,25(OH) 2 D 3 in childhood.
Introduction
Vitamin D deficiency, serum level less than 20 ng/mL (50 nmol/L) or insufficiency, serum level 20 to 29 ng/mL (50-75 nmol/L) is common with an estimated 1 billion people having either condition worldwide [1] . In Australia about 30% of adults have vitamin D insufficiency [2] and a recent report showed that over 16% of Australian infants were vitamin D insufficient [3] . In addition to its metabolic role in skeletal health and calcium homeostasis, vitamin D insufficiency may be associated with an increased risk of several other adverse health outcomes such as multiple sclerosis [4] , cancer, type 1 and type 2 diabetes [5] .
Vitamin D 3 is synthesised in the epidermis from 7-dehydrocholesterol (7-DHC) in a reaction catalysed by ultraviolet B (UVB). About 85%-90% of vitamin D is carried in blood circulation by the vitamin D binding protein (VDBP) which has common genetic polymorphisms that produce variant proteins that differ in their affinity for vitamin D and affect its bioavailable levels [6] . New polyclonal and proteomic methods to measure vitamin D-binding protein will enhance our ability to understand its biological role [7] . Vitamin D 3 is then rapidly hydroxylated in the liver to 25-hydroxyvitamin D 3 , then hydroxylated into its biologically active form, 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) mainly in the kidneys. While the latter is the biologically active form, it has extremely low circulating levels, (partly related to a relatively short circulating half-life) resulting in challenging analytical detectability, using most currently available assays. Furthermore, whilst 25 hydroxylases are relatively unregulated, renal 1 α-hydroxylase is tightly regulated in an endocrine fashion, by hormones including parathyroid hormone and fibroblast growth factor 23 (FGF23). Consequently, 25(OH)D 3 is the current recommended biomarker for vitamin D status [8] as it is the substrate for conversion to the active 1,25(OH) 2 D 3 and its concentration reflects hepatic vitamin D stores.
Many studies have shown that environmental factors such as sun exposure, life style factors [9] , ultraviolet radiation (UVR) [10] and skin pigmentation [11] are associated with 25(OH)D 3 concentrations. Genetic factors also influence circulating vitamin D concentrations [12] [13] [14] [15] [16] . Genomewide association studies (GWAS) have shown that multiple single nucleotide polymorphisms (SNPs) located at or near vitamin D metabolic pathway genes, such as 24-hydoxylase (CYP24A1) and vitamin D binding protein (GC) are associated with serum 25(OH)D 3 concentrations [14] [15] [16] , accounting for 1%-4% of its overall variance [16] .
Few studies have comprehensively examined both environmental and genetic factors in parallel. Previously we reported that sun exposure-related factors account for 36%, genetic factors account for 14% and skin phenotypes accounts for 3.5% of 25(OH)D 3 variation in an Australian adult population [17] . In a separate study of Australian infants, we found that ambient UVR levels 6 weeks before blood collection can predict 10% of 25(OH)D 3 variation [3] 
Materials and methods

Participants
This study is based on a sample of 322 unselected control children from the Early Environment and Type 1 Diabetes Prevention Project. They were all born and residing in Victoria, and were recruited between March 2008 and November 2011 at the Royal Children's Hospital Day Surgery Unit Melbourne, Australia (latitude 38° South, 145° East).
Children under 18 years admitted for a 1-day surgical procedure, such as plastic surgery, eye surgery, circumcision, hernia repair and others, were eligible to participate in the study. Children who had severe congenital abnormalities, prolonged physical or mental illness, which may affect their activity such as playing, walking, or attending normal school, were excluded. The median age at recruitment was 8.42 years (IQR 6.26-11.06 years) and they were divided into three age groups <5, 5-10 and >10 years (see Table 1 ), 55% were males and the majority (62.4%) were Caucasians.
Children and their guardians (usually parents) were interviewed by trained research nurses who conducted clinical examinations and helped parents to complete the questionnaires on the day of admission. The questionnaires collected information on direct sun exposure behaviours of both children and parents, including how much time they usually spent in the sun during summer and winter, on weekends and weekdays, and freckling by the end of summer using previously validated instruments [18] .
Ethics approval was obtained from the Human Research Ethics Committee of the Royal Children's Hospital, Melbourne, Australia. Informed, written consent for the study was obtained from parents/ guardians, and from children 12 years of age and older.
Examination data
The research nurses conducted the examination and noted the natural skin, hair and eye colour using standardized coloured photographs which we have previously shown to explain 39.7% (p < 0.001) of the variation in constitutive skin pigmentation measured by spectrophotometer [19] . Child ethnicity (Caucasian, Asian, African, Aboriginal or Torres Strait Islander, Middle Eastern or other) was determined by parental report. The number of naevi on the left arm was counted using a standardised protocol [20] . Height and weight was measured and body mass index [BMI = weight (kg)/height (m 2 )] was calculated. Gender-and age-specific BMI cut off points were used to classify children as normal, overweight or obese [21] .
Monthly average of the total daily ambient UVR dose was obtained in Standard Erythemal Dose units for Melbourne from 2008 to 2011 [22] . The interview months' UVR was calculated as the average of daily total UVR assessed on the year and month of the interview. Likewise, the UVR for 1 month, 6 weeks and 2 months before the interview were determined [19] .
Laboratory data
All 322 children provided a peripheral blood sample, which was separated to isolate plasma from the cellular component within 2 h of collection. DNA was extracted from the white blood cell component using the Qiagen Flexigene Kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions.
Up to 10 mL peripheral blood samples were collected in EDTA tubes for each child prior to anaesthesia which were centrifuged within 2 h. Plasma and plasma-depleted whole blood were stored at −70°C until analysis. Plasma 25(OH)D 3 and 1,25(OH) 2 D 3 were measured with selective solid-phase extraction capillary liquid chromatography-tandem mass spectrometry at the Qu Lab, University at Buffalo, New York. This central laboratory has achieved a limit of quantification of 5.04 pg/mL (12 pmol/L) and 0.1 ng/mL (0.25 nmol/L), interday accuracy of 9.5%-13.3% and 2.7%-14% and interday precision of 6.7%-16.6% and 3.1%-8.0% for 1,25(OH) 2 D 3 and 25(OH)D 3 , respectively [23] . In DEQAS report the deviations were all <18.4% from two batches of samples. The nine-point calibration curve showed excellent linearity with correlation coefficient greater than 0.99 for both 25 [24] . Thus, the possible interfering effect of these metabolites in 25(OH)D 3 and 1,25(OH) 2 D 3 measurements has been removed.
Based on the evidence of their association with circulating vitamin D from past genetic association studies, we selected 12 SNPs located at or near genes related to the vitamin D metabolic pathway (CYP2R1 (rs10741657), DHCR7 (rs12785878), CYP24A1 (rs6013897, rs2181874, rs2762941, rs4809960), GC (rs4588, rs2282679) VDR (rs11168275, rs4760655), and skin pigmentation genes (rs8045560, rs3936623) [16, 25, 26] . Genotyping was performed using the Sequenom Mass Array system, of which a detailed description of the assay has been published elsewhere [27] . Sequenom iPlex chemistry was used according to manufacturer instructions. Cluster plots for all 'non-conservative' genotype calls were manually inspected and regenotyping was done if necessary. After the exclusion of samples not meeting the quality control threshold (departure from the HardyWeinberg equilibrium p < 0.01 and <90% call rate), genotype data for 311 participants were generated.
Allele scores and SNPs selection
We constructed two vitamin D allele scores, synthesis score (Synscore) and metabolic score (Metscore), using four out of the 12 examined vitamin D-related SNPs. CYP2R1 (rs10741657), DHCR7 (rs12785878), CYP24A1 (rs6013897) and GC (rs2282679), were selected based on findings from the GWAS of the SUNLIGHT Consortium and our univariate results (data not shown) [16, 28] . DHCR7 (rs12785878) and CYP2R1 (rs10741657) are in genes located upstream, and CYP24A1 (rs6013897) and GC (rs2282679) are in genes located downstream of 25(OH)D 3 production (metabolism). Synscore is the sum of the vitamin D-increasing alleles in the upstream genes (CYP2R1 and DHCR7 with a score range 0-4) and Metscore is the sum of vitamin D-increasing alleles in the gene located downstream (GC and CYP24A1 with a score range 0-4) of 25(OH)D 3 [29] .
These allelic scores can be used as instrumental variables for 25(OH)D 3 and 1,25(OH) 2 D 3 concentration when testing, in Mendelian randomisation analysis, for likely causal association as it represents variants with direct effect on substrate availability for vitamin D metabolites' synthesis.
Statistical analysis
In the univariate analysis, linear regression models were used to examine the environmental, and genetic determinants of 25(OH)D 3 and 1,25(OH) 2 D 3 concentrations. The distribution of both vitamin D metabolites was skewed and thus log-transformed prior to analysis to improve normality and allow parametric statistical analysis. Logscale summary values were presented and regression coefficients were interpreted as percent change in outcome per 1 unit change in exposure variable (% change = 1 − exp(β) for negative β or exp(β)-1 for positive β). As 25(OH)D 3 and 1,25(OH) 2 D 3 had very different blood levels and units (measured in nmol/L and pmol/L for 25(OH)D 3 and 1,25(OH) 2 D 3 , respectively), the log values and their relative change allowed easier comparison and interpretation of the determinants' effect on these metabolites.
For models not including UVR as a potential confounder, deseasonalised vitamin D concentrations were used as the outcome measure to correct for seasonal variation. We calculated deseasonalised 25(OH)D 3 and 1,25(OH) 2 D 3 by removing the seasonal variation. We fitted sinusoidal model to data on 25(OH)D 3 and 1,25(OH) 2 D 3 levels and month (t) of sample collection to model seasonal variation [30, 31] :
The amplitude was calculated using the formula √( β 1 2 + β 2 2 ). This predicted value was subtracted from the actual value and added to the overall mean. For some analyses it is of interest to remove the natural seasonal fluctuation in vitamin D levels by deseasonalisation which has been used in previous studies [30, 31] .
To construct the final predictive model, we used forward stepwise regression starting with one variable in the model, testing the addition of each variable, based on its R-square from the univariate analysis and its impact on model improvement, until there was no improvement of the model using the likelihood ratio test. Interaction between predictors for both 25(OH)D 3 and 1,25(OH) 2 D 3 concentrations in the final models was assessed by the P-value associated with the Wald test of a product term for the relevant factors in categorical terms.
We used Stata version 14 (StataCorp, College Station, TX, USA) for all analyses.
Results
Demographic and anthropometric mesures of the participants (n = 322) with the corresponding mean of natural-log-transformed serum 25(OH)D 3 and 1,25(OH) 2 D 3 concentrations are presented in Table 1 Higher ambient UVR, in various time intervals prior to sample collection were strongly associated with both 25(OH)D 3 and 1,25(OH) 2 D 3 blood concentrations. We examined the association of ambient UVR in the month of blood collection and 1 month, 6 weeks and 2 months before blood collection, with both metabolites. The ambient UVR in 6 weeks before sample collection had the strongest magnitude of effect on both 25(OH)D 3 and 1,25(OH) 2 D 3 ( Table 2 ).
Phenotypic and environmental factors
The associations between selected factors, based on their statistical significance and r 2 , and vitamin D concentration (25(OH)D 3 and 1,25(OH) 2 D 3 ) in univariate analysis are presented in Table 2 Child skin reaction during sun exposure, lifetime sun burns, freckling by the end of last summer and time in the sun during last summer and winter were associated with higher deseasonalised 25(OH)D 3 concentrations (Table 2) . Only lifetime sun burns were associated with higher deseasonalised 1,25(OH) 2 D 3 concentrations.
Variation in 25(OH)D 3 and 1,25(OH) 2 D 3 concentrations with genetic factors
Of the 12 selected SNPs, rs2282679, rs4588 (GC), rs6013897 (CYP24A1), rs12785878 (DHCR7), and rs10741657 (CYP2R1) were associated with higher concentrations of both deseasonalised 25 
Final predictive models for 25(OH)D 3 and 1,25(OH) 2 D 3 concentrations
The final predictive model for 25(OH)D 3 retained seven important factors: UVR 6 weeks before interview, ethnicity, skin colour, height, history of sun burn during life-time, Synscore and Metscore. Overall, these factors explained more than 43% of the variation in serum 25(OH)D 3 concentrations. In contrast, the final predictive model for 1,25(OH) 2 D 3 retained four factors: UVR 6 weeks before interview, eye colour, height and Metscore. These factors explained over 25% of the variation of this biological active metabolite (Table 4) . Strengths of this study include the detailed childhood sun exposure behaviours as well as extensive environmental data that enabled us to explore the interplay between genetic and environmental determinants. Another strength is the use of the genetic data to construct a genetic score and its inclusion into the predictive models for both metabolites. Melbourne, Australia is well suited to this type of investigation as it is a city where vitamin D food fortification is uncommon and child supplementation is not routinely given. Despite a relatively large population, some of our findings were limited in power due to small numbers for particular genotypes and ethnic groups. Limitations of our study also include ethnicity was limited to parental report. However, it was consistent with the finding from the objective skin type assessment. Only a very basic dietary assessment was carried out and the use of vitamin D supplements in the last year was not recorded, (would be very low in our studied population as the major source of vitamin D was assumed to be sunlight exposure) [32] . In addition, our data did not include information about serum calcium, phosphate and parathyroid hormone concentrations which may contribute to the tight regulation of 1,25(OH) 2 D 3 concentrations [33, 34] via renal 1 α-hydroxylation. Table 2 .
The finding that UVR levels at 6 weeks before interview had the strongest association with 25(OH)D 3 was consistent with recent findings from Australia [17, 35] and Canada [36] . Previous studies have identified seasonal variation in 1,25(OH) 2 [39] .
Most previous studies showed a consistent effect of CYP2R1 (rs10741657) [16, 40, 41] , DHCR7 (rs12785878) [16, 42] , CYP24A1 (rs6013897) [16, 40] and GC (rs2282679) [16, 40, 41] which was found to be associated with vitamin D concentrations in our study. GC-globulin is the major VDBP which acts as a transporter for both 25(OH)D 3 and 1,25(OH) 2 D 3 leaving <0.1% and <1%, respectively, to circulate in free form [43, 44] . Lower VDBP, which is linked to GC variants, were previously reported to be associated with low 25(OH)D 3 concentrations [16] . Combining GC variants with CYP24A1 (rs6013897) on Metscore provided a more powerful instrument for the prediction of 25(OH)D 3 concentrations in our study which is consistent with a previous report [29] . Interestingly, we extend this concept to the association of Metscore with 1,25(OH) 2 D 3 concentrations and showed the same pattern. This suggests that bioavailability of both metabolites are affected by these gene variants.
Although the final predictive models demonstrated here were only able to account for 43% and 25% of 25(OH)D 3 and 1,25(OH) 2 D 3 concentrations, respectively. This compares well with the 1%-4% accounted for by genetic factors in a vitamin D GWAS study [16] . Previously, a vitamin D synthesis or metabolism score has been successfully used as an instrumental variable in a Mendelian randomisation study [28] . Here 
Conclusions
Here, we have developed predictive models for both 25(OH)D 3 and 1,25(OH) 2 D 3 concentrations in a population of Australian children. These findings are based on a multiethnic population and can be generalised to healthy child populations. The findings highlight the importance of both environmental factors, in particular ambient UVR levels 6 weeks before blood collection, and genetic factors in determining both 25(OH)D 3 and 1,25(OH) 2 D 3 concentrations in children.
